These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8462002)

  • 1. Angiotensin II decreases the rate of production of cerebrospinal fluid.
    Maktabi MA; Stachovic GC; Faraci FM
    Brain Res; 1993 Mar; 606(1):44-9. PubMed ID: 8462002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous angiotensin II inhibits production of cerebrospinal fluid during posthypoxemic reoxygenation in the rabbit.
    Maktabi MA; Faraci FM
    Stroke; 1994 Jul; 25(7):1489-93; discussion 1494. PubMed ID: 8023367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of angiotensin II in regulation of cerebrospinal fluid formation in rabbits.
    Chodobski A; Szmydynger-Chodobska J; Segal MB; McPherson IA
    Brain Res; 1992 Oct; 594(1):40-6. PubMed ID: 1467940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin II on blood flow to choroid plexus.
    Maktabi MA; Heistad DD; Faraci FM
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H414-8. PubMed ID: 2309908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane decreases the rate of production of cerebrospinal fluid. Possible role of vasopressin V1 receptors.
    Maktabi MA; Elbokl FF; Faraci FM; Todd MM
    Anesthesiology; 1993 Jan; 78(1):72-82. PubMed ID: 8424575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of central administration of angiotensin II on cerebrospinal fluid formation in rabbits.
    Chodobski A; Szmydynger-Chodobska J; Segal MB; McPherson IA
    Prog Brain Res; 1992; 91():19-22. PubMed ID: 1410404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of acetazolamide on the choroid plexus.
    Faraci FM; Mayhan WG; Heistad DD
    J Pharmacol Exp Ther; 1990 Jul; 254(1):23-7. PubMed ID: 2114478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vasopressin on production of cerebrospinal fluid: possible role of vasopressin (V1)-receptors.
    Faraci FM; Mayhan WG; Heistad DD
    Am J Physiol; 1990 Jan; 258(1 Pt 2):R94-8. PubMed ID: 2137302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II contributes to cerebral vasodilatation during hypoxia in the rabbit.
    Maktabi MA; Todd MM; Stachovic G
    Stroke; 1995 Oct; 26(10):1871-6. PubMed ID: 7570741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central angiotensin II receptor antagonism on fetal swallowing and cardiovascular activity.
    El-Haddad MA; Chao CR; Sayed AA; El-Haddad H; Ross MG
    Am J Obstet Gynecol; 2001 Oct; 185(4):828-33. PubMed ID: 11641660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT1 receptor subtype mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation in the rat.
    Chodobski A; Szmydynger-Chodobska J; Vannorsdall MD; Epstein MH; Johanson CE
    Regul Pept; 1994 Sep; 53(2):123-9. PubMed ID: 7831501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of arginine vasopressin, acetazolamide, and angiotensin II on CSF pressure at simulated altitude.
    Senay LC; Tolbert DL
    Aviat Space Environ Med; 1984 May; 55(5):370-6. PubMed ID: 6732691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of angiotensin II in the regulation of blood flow to choroid plexuses and cerebrospinal fluid formation in the rat.
    Chodobski A; Szmydynger-Chodobska J; Epstein MH; Johanson CE
    J Cereb Blood Flow Metab; 1995 Jan; 15(1):143-51. PubMed ID: 7798332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of central and intravascular angiotensin I and II on the choroid plexus.
    Maktabi MA; Heistad DD; Faraci FM
    Am J Physiol; 1991 Nov; 261(5 Pt 2):R1126-32. PubMed ID: 1951760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acetazolamide and furosemide on the production and composition of cerebrospinal fluid from the cat choroid plexus.
    Melby JM; Miner LC; Reed DJ
    Can J Physiol Pharmacol; 1982 Mar; 60(3):405-9. PubMed ID: 7074425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin converting enzyme inhibitor cilazapril and angiotensin II antagonist saralasin in ovarian hyperstimulation syndrome in the rabbit.
    Sahin Y; Kontaş O; Müderris II; Cankurtaran M
    Gynecol Endocrinol; 1997 Aug; 11(4):231-6. PubMed ID: 9272418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central role for angiotensin in control of adrenal catecholamine secretion.
    Corwin EJ; Seaton JF; Hamaji M; Harrison TS
    Am J Physiol; 1985 Mar; 248(3 Pt 2):R363-70. PubMed ID: 3976910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for sar1-ala8-angiotensin crossing the blood cerebrospinal fluid barrier to antagonize central effects of angiotensin II.
    Hoffman WE; Phillips MI
    Brain Res; 1976 Jun; 109(3):541-52. PubMed ID: 1276934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation.
    Chodobski A; Szmydynger-Chodobska J; Johanson CE
    Eur J Pharmacol; 1998 Apr; 347(2-3):205-9. PubMed ID: 9653883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of choroid plexus carbonic anhydrase activity to cerebrospinal fluid formation: study of three inhibitors in cat with extrapolation to man.
    Vogh BP
    J Pharmacol Exp Ther; 1980 May; 213(2):321-31. PubMed ID: 7365692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.